Routine board appointment with no immediate financial or strategic implications. Monitor for future committee assignments or any related party transactions, though none were disclosed.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $405.12entry
- T+1 · 6d ago −0.54%α −1.86% · $402.94
- T+4 · todayOpen
- T+5 · in 3h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
UnitedHealth Group appointed Madeline Bell, former president and CEO of Children's Hospital of Philadelphia, as an independent director effective November 3, 2026. This is a routine board addition with no financial impact or change to management.
Key Facts
- Madeline Bell appointed as independent director effective November 3, 2026
- Bell is former president and CEO of Children's Hospital of Philadelphia (CHOP), retired last month
- She has not yet been appointed to any board committees
- Compensation follows standard non-employee director program, described in the 2026 proxy statement
- Company entered into standard form indemnification agreement with Bell
Financial Impact
No financial figures disclosed; routine director compensation per standard program
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000731766-26-000274 |
| Exhibit: exhibit9911.htm | 0000731766-26-000274 |
| Document: 0000731766-26-000274-index-headers.html | 0000731766-26-000274 |
| Document: 0000731766-26-000274-index.html | 0000731766-26-000274 |
| Document: 0000731766-26-000274.txt | 0000731766-26-000274 |
Track record
63 reports on UNH
13 of 16 bullish or bearish reports moved the stock their way by T+1. Best: +23.07% at T+60 after the Apr 22, 2026 report. 13 of 16 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $407.00 Now $412.02 +1.23% settles Nov 17
- Nov 9, 20267d ago 8-K Neutral 2/10 Viewing Entry $405.12 to $402.94 Now $412.02 +1.70% ▼ −0.54% −1.86% vs SPY
- Oct 20, 202627d ago Institutional Cluster Mixed 4/10 Entry $417.00 to $424.98 Now $412.02 −1.19% ▲ +1.91% +3.09% vs SPY
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $377.76 to $395.62 Now $412.02 +9.07% ▲ +4.73% +5.81% vs SPY
- Oct 1, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $371.90 to $378.58 Now $412.02 +10.79% ▲ +1.80% +1.12% vs SPY
- Sep 30, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $365.20 to $371.90 Now $412.02 +12.82% ▲ +1.83% +1.10% vs SPY
- Sep 30, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $365.20 to $371.90 Now $412.02 +12.82% ▲ +1.83% +1.10% vs SPY
- Sep 30, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $365.20 to $371.90 Now $412.02 +12.82% ▲ +1.83% +1.10% vs SPY
- Sep 17, 20268w ago GOVT-CONTRACT Neutral 2/10 Entry $376.90 to $377.56 Now $412.02 +9.32% ▲ +0.18% −1.38% vs SPY
- Sep 11, 20269w ago Court Ruling Bullish 5/10 Entry $383.55 to $375.93 Now $412.02 +7.42% ▼ −1.99% −1.53% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers